Report Overview
Evolution of monoclonal antibodies has resulted in the next generation of antibody therapeutics, with engineering to enhance characteristics such as target cell�killing potency. These include antibody�drug conjugates (ADCs), bispecific antibodies, engineered antibodies, antibody fragments, and nanobodies.
The global Next Generation Monoclonal Antibodies market size was estimated at USD 13250 million in 2023 and is projected to reach USD 69920.82 million by 2032, exhibiting a CAGR of 20.30% during the forecast period.
North America Next Generation Monoclonal Antibodies market size was estimated at USD 4758.60 million in 2023, at a CAGR of 17.40% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Next Generation Monoclonal Antibodies market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Next Generation Monoclonal Antibodies Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Next Generation Monoclonal Antibodies market in any manner.
Global Next Generation Monoclonal Antibodies Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Amgen
Pfizer
Takeda
Daiichi Sankyo
Seagen
Astellas
Gilead Sciences
GSK
Immunocore
ADC Therapeutics
Bayer
Novartis
Lantheus
Aurobindo Pharma
Mundipharma
AbbVie
Market Segmentation (by Type)
Antibody Drug Conjugate (ADC)
Bispecific Antibody (BsAb)
Antibody-radionuclide Conjugates
Market Segmentation (by Application)
Immune Diseases
Cancer
Other
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Next Generation Monoclonal Antibodies Market
� Overview of the regional outlook of the Next Generation Monoclonal Antibodies Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Next Generation Monoclonal Antibodies Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Next Generation Monoclonal Antibodies, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Next Generation Monoclonal Antibodies
1.2 Key Market Segments
1.2.1 Next Generation Monoclonal Antibodies Segment by Type
1.2.2 Next Generation Monoclonal Antibodies Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Next Generation Monoclonal Antibodies Market Overview
2.1 Global Market Overview
2.1.1 Global Next Generation Monoclonal Antibodies Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Next Generation Monoclonal Antibodies Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Next Generation Monoclonal Antibodies Market Competitive Landscape
3.1 Global Next Generation Monoclonal Antibodies Sales by Manufacturers (2019-2025)
3.2 Global Next Generation Monoclonal Antibodies Revenue Market Share by Manufacturers (2019-2025)
3.3 Next Generation Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Next Generation Monoclonal Antibodies Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Next Generation Monoclonal Antibodies Sales Sites, Area Served, Product Type
3.6 Next Generation Monoclonal Antibodies Market Competitive Situation and Trends
3.6.1 Next Generation Monoclonal Antibodies Market Concentration Rate
3.6.2 Global 5 and 10 Largest Next Generation Monoclonal Antibodies Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Next Generation Monoclonal Antibodies Industry Chain Analysis
4.1 Next Generation Monoclonal Antibodies Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Next Generation Monoclonal Antibodies Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Next Generation Monoclonal Antibodies Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Next Generation Monoclonal Antibodies Sales Market Share by Type (2019-2025)
6.3 Global Next Generation Monoclonal Antibodies Market Size Market Share by Type (2019-2025)
6.4 Global Next Generation Monoclonal Antibodies Price by Type (2019-2025)
7 Next Generation Monoclonal Antibodies Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Next Generation Monoclonal Antibodies Market Sales by Application (2019-2025)
7.3 Global Next Generation Monoclonal Antibodies Market Size (M USD) by Application (2019-2025)
7.4 Global Next Generation Monoclonal Antibodies Sales Growth Rate by Application (2019-2025)
8 Next Generation Monoclonal Antibodies Market Consumption by Region
8.1 Global Next Generation Monoclonal Antibodies Sales by Region
8.1.1 Global Next Generation Monoclonal Antibodies Sales by Region
8.1.2 Global Next Generation Monoclonal Antibodies Sales Market Share by Region
8.2 North America
8.2.1 North America Next Generation Monoclonal Antibodies Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Next Generation Monoclonal Antibodies Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Next Generation Monoclonal Antibodies Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Next Generation Monoclonal Antibodies Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Next Generation Monoclonal Antibodies Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Next Generation Monoclonal Antibodies Market Production by Region
9.1 Global Production of Next Generation Monoclonal Antibodies by Region (2019-2025)
9.2 Global Next Generation Monoclonal Antibodies Revenue Market Share by Region (2019-2025)
9.3 Global Next Generation Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Next Generation Monoclonal Antibodies Production
9.4.1 North America Next Generation Monoclonal Antibodies Production Growth Rate (2019-2025)
9.4.2 North America Next Generation Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Next Generation Monoclonal Antibodies Production
9.5.1 Europe Next Generation Monoclonal Antibodies Production Growth Rate (2019-2025)
9.5.2 Europe Next Generation Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Next Generation Monoclonal Antibodies Production (2019-2025)
9.6.1 Japan Next Generation Monoclonal Antibodies Production Growth Rate (2019-2025)
9.6.2 Japan Next Generation Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Next Generation Monoclonal Antibodies Production (2019-2025)
9.7.1 China Next Generation Monoclonal Antibodies Production Growth Rate (2019-2025)
9.7.2 China Next Generation Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Roche
10.1.1 Roche Next Generation Monoclonal Antibodies Basic Information
10.1.2 Roche Next Generation Monoclonal Antibodies Product Overview
10.1.3 Roche Next Generation Monoclonal Antibodies Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche Next Generation Monoclonal Antibodies SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Amgen
10.2.1 Amgen Next Generation Monoclonal Antibodies Basic Information
10.2.2 Amgen Next Generation Monoclonal Antibodies Product Overview
10.2.3 Amgen Next Generation Monoclonal Antibodies Product Market Performance
10.2.4 Amgen Business Overview
10.2.5 Amgen Next Generation Monoclonal Antibodies SWOT Analysis
10.2.6 Amgen Recent Developments
10.3 Pfizer
10.3.1 Pfizer Next Generation Monoclonal Antibodies Basic Information
10.3.2 Pfizer Next Generation Monoclonal Antibodies Product Overview
10.3.3 Pfizer Next Generation Monoclonal Antibodies Product Market Performance
10.3.4 Pfizer Next Generation Monoclonal Antibodies SWOT Analysis
10.3.5 Pfizer Business Overview
10.3.6 Pfizer Recent Developments
10.4 Takeda
10.4.1 Takeda Next Generation Monoclonal Antibodies Basic Information
10.4.2 Takeda Next Generation Monoclonal Antibodies Product Overview
10.4.3 Takeda Next Generation Monoclonal Antibodies Product Market Performance
10.4.4 Takeda Business Overview
10.4.5 Takeda Recent Developments
10.5 Daiichi Sankyo
10.5.1 Daiichi Sankyo Next Generation Monoclonal Antibodies Basic Information
10.5.2 Daiichi Sankyo Next Generation Monoclonal Antibodies Product Overview
10.5.3 Daiichi Sankyo Next Generation Monoclonal Antibodies Product Market Performance
10.5.4 Daiichi Sankyo Business Overview
10.5.5 Daiichi Sankyo Recent Developments
10.6 Seagen
10.6.1 Seagen Next Generation Monoclonal Antibodies Basic Information
10.6.2 Seagen Next Generation Monoclonal Antibodies Product Overview
10.6.3 Seagen Next Generation Monoclonal Antibodies Product Market Performance
10.6.4 Seagen Business Overview
10.6.5 Seagen Recent Developments
10.7 Astellas
10.7.1 Astellas Next Generation Monoclonal Antibodies Basic Information
10.7.2 Astellas Next Generation Monoclonal Antibodies Product Overview
10.7.3 Astellas Next Generation Monoclonal Antibodies Product Market Performance
10.7.4 Astellas Business Overview
10.7.5 Astellas Recent Developments
10.8 Gilead Sciences
10.8.1 Gilead Sciences Next Generation Monoclonal Antibodies Basic Information
10.8.2 Gilead Sciences Next Generation Monoclonal Antibodies Product Overview
10.8.3 Gilead Sciences Next Generation Monoclonal Antibodies Product Market Performance
10.8.4 Gilead Sciences Business Overview
10.8.5 Gilead Sciences Recent Developments
10.9 GSK
10.9.1 GSK Next Generation Monoclonal Antibodies Basic Information
10.9.2 GSK Next Generation Monoclonal Antibodies Product Overview
10.9.3 GSK Next Generation Monoclonal Antibodies Product Market Performance
10.9.4 GSK Business Overview
10.9.5 GSK Recent Developments
10.10 Immunocore
10.10.1 Immunocore Next Generation Monoclonal Antibodies Basic Information
10.10.2 Immunocore Next Generation Monoclonal Antibodies Product Overview
10.10.3 Immunocore Next Generation Monoclonal Antibodies Product Market Performance
10.10.4 Immunocore Business Overview
10.10.5 Immunocore Recent Developments
10.11 ADC Therapeutics
10.11.1 ADC Therapeutics Next Generation Monoclonal Antibodies Basic Information
10.11.2 ADC Therapeutics Next Generation Monoclonal Antibodies Product Overview
10.11.3 ADC Therapeutics Next Generation Monoclonal Antibodies Product Market Performance
10.11.4 ADC Therapeutics Business Overview
10.11.5 ADC Therapeutics Recent Developments
10.12 Bayer
10.12.1 Bayer Next Generation Monoclonal Antibodies Basic Information
10.12.2 Bayer Next Generation Monoclonal Antibodies Product Overview
10.12.3 Bayer Next Generation Monoclonal Antibodies Product Market Performance
10.12.4 Bayer Business Overview
10.12.5 Bayer Recent Developments
10.13 Novartis
10.13.1 Novartis Next Generation Monoclonal Antibodies Basic Information
10.13.2 Novartis Next Generation Monoclonal Antibodies Product Overview
10.13.3 Novartis Next Generation Monoclonal Antibodies Product Market Performance
10.13.4 Novartis Business Overview
10.13.5 Novartis Recent Developments
10.14 Lantheus
10.14.1 Lantheus Next Generation Monoclonal Antibodies Basic Information
10.14.2 Lantheus Next Generation Monoclonal Antibodies Product Overview
10.14.3 Lantheus Next Generation Monoclonal Antibodies Product Market Performance
10.14.4 Lantheus Business Overview
10.14.5 Lantheus Recent Developments
10.15 Aurobindo Pharma
10.15.1 Aurobindo Pharma Next Generation Monoclonal Antibodies Basic Information
10.15.2 Aurobindo Pharma Next Generation Monoclonal Antibodies Product Overview
10.15.3 Aurobindo Pharma Next Generation Monoclonal Antibodies Product Market Performance
10.15.4 Aurobindo Pharma Business Overview
10.15.5 Aurobindo Pharma Recent Developments
10.16 Mundipharma
10.16.1 Mundipharma Next Generation Monoclonal Antibodies Basic Information
10.16.2 Mundipharma Next Generation Monoclonal Antibodies Product Overview
10.16.3 Mundipharma Next Generation Monoclonal Antibodies Product Market Performance
10.16.4 Mundipharma Business Overview
10.16.5 Mundipharma Recent Developments
10.17 AbbVie
10.17.1 AbbVie Next Generation Monoclonal Antibodies Basic Information
10.17.2 AbbVie Next Generation Monoclonal Antibodies Product Overview
10.17.3 AbbVie Next Generation Monoclonal Antibodies Product Market Performance
10.17.4 AbbVie Business Overview
10.17.5 AbbVie Recent Developments
11 Next Generation Monoclonal Antibodies Market Forecast by Region
11.1 Global Next Generation Monoclonal Antibodies Market Size Forecast
11.2 Global Next Generation Monoclonal Antibodies Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Next Generation Monoclonal Antibodies Market Size Forecast by Country
11.2.3 Asia Pacific Next Generation Monoclonal Antibodies Market Size Forecast by Region
11.2.4 South America Next Generation Monoclonal Antibodies Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Next Generation Monoclonal Antibodies by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Next Generation Monoclonal Antibodies Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Next Generation Monoclonal Antibodies by Type (2025-2032)
12.1.2 Global Next Generation Monoclonal Antibodies Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Next Generation Monoclonal Antibodies by Type (2025-2032)
12.2 Global Next Generation Monoclonal Antibodies Market Forecast by Application (2025-2032)
12.2.1 Global Next Generation Monoclonal Antibodies Sales (K MT) Forecast by Application
12.2.2 Global Next Generation Monoclonal Antibodies Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Next Generation Monoclonal Antibodies Market Size Comparison by Region (M USD)
Table 5. Global Next Generation Monoclonal Antibodies Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Next Generation Monoclonal Antibodies Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Next Generation Monoclonal Antibodies Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Next Generation Monoclonal Antibodies Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Monoclonal Antibodies as of 2022)
Table 10. Global Market Next Generation Monoclonal Antibodies Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Next Generation Monoclonal Antibodies Sales Sites and Area Served
Table 12. Manufacturers Next Generation Monoclonal Antibodies Product Type
Table 13. Global Next Generation Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Next Generation Monoclonal Antibodies
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Next Generation Monoclonal Antibodies Market Challenges
Table 22. Global Next Generation Monoclonal Antibodies Sales by Type (K MT)
Table 23. Global Next Generation Monoclonal Antibodies Market Size by Type (M USD)
Table 24. Global Next Generation Monoclonal Antibodies Sales (K MT) by Type (2019-2025)
Table 25. Global Next Generation Monoclonal Antibodies Sales Market Share by Type (2019-2025)
Table 26. Global Next Generation Monoclonal Antibodies Market Size (M USD) by Type (2019-2025)
Table 27. Global Next Generation Monoclonal Antibodies Market Size Share by Type (2019-2025)
Table 28. Global Next Generation Monoclonal Antibodies Price (USD/MT) by Type (2019-2025)
Table 29. Global Next Generation Monoclonal Antibodies Sales (K MT) by Application
Table 30. Global Next Generation Monoclonal Antibodies Market Size by Application
Table 31. Global Next Generation Monoclonal Antibodies Sales by Application (2019-2025) & (K MT)
Table 32. Global Next Generation Monoclonal Antibodies Sales Market Share by Application (2019-2025)
Table 33. Global Next Generation Monoclonal Antibodies Sales by Application (2019-2025) & (M USD)
Table 34. Global Next Generation Monoclonal Antibodies Market Share by Application (2019-2025)
Table 35. Global Next Generation Monoclonal Antibodies Sales Growth Rate by Application (2019-2025)
Table 36. Global Next Generation Monoclonal Antibodies Sales by Region (2019-2025) & (K MT)
Table 37. Global Next Generation Monoclonal Antibodies Sales Market Share by Region (2019-2025)
Table 38. North America Next Generation Monoclonal Antibodies Sales by Country (2019-2025) & (K MT)
Table 39. Europe Next Generation Monoclonal Antibodies Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Next Generation Monoclonal Antibodies Sales by Region (2019-2025) & (K MT)
Table 41. South America Next Generation Monoclonal Antibodies Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Next Generation Monoclonal Antibodies Sales by Region (2019-2025) & (K MT)
Table 43. Global Next Generation Monoclonal Antibodies Production (K MT) by Region (2019-2025)
Table 44. Global Next Generation Monoclonal Antibodies Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Next Generation Monoclonal Antibodies Revenue Market Share by Region (2019-2025)
Table 46. Global Next Generation Monoclonal Antibodies Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Next Generation Monoclonal Antibodies Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Next Generation Monoclonal Antibodies Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Next Generation Monoclonal Antibodies Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Next Generation Monoclonal Antibodies Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Roche Next Generation Monoclonal Antibodies Basic Information
Table 52. Roche Next Generation Monoclonal Antibodies Product Overview
Table 53. Roche Next Generation Monoclonal Antibodies Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Roche Business Overview
Table 55. Roche Next Generation Monoclonal Antibodies SWOT Analysis
Table 56. Roche Recent Developments
Table 57. Amgen Next Generation Monoclonal Antibodies Basic Information
Table 58. Amgen Next Generation Monoclonal Antibodies Product Overview
Table 59. Amgen Next Generation Monoclonal Antibodies Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Amgen Business Overview
Table 61. Amgen Next Generation Monoclonal Antibodies SWOT Analysis
Table 62. Amgen Recent Developments
Table 63. Pfizer Next Generation Monoclonal Antibodies Basic Information
Table 64. Pfizer Next Generation Monoclonal Antibodies Product Overview
Table 65. Pfizer Next Generation Monoclonal Antibodies Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Pfizer Next Generation Monoclonal Antibodies SWOT Analysis
Table 67. Pfizer Business Overview
Table 68. Pfizer Recent Developments
Table 69. Takeda Next Generation Monoclonal Antibodies Basic Information
Table 70. Takeda Next Generation Monoclonal Antibodies Product Overview
Table 71. Takeda Next Generation Monoclonal Antibodies Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Takeda Business Overview
Table 73. Takeda Recent Developments
Table 74. Daiichi Sankyo Next Generation Monoclonal Antibodies Basic Information
Table 75. Daiichi Sankyo Next Generation Monoclonal Antibodies Product Overview
Table 76. Daiichi Sankyo Next Generation Monoclonal Antibodies Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Daiichi Sankyo Business Overview
Table 78. Daiichi Sankyo Recent Developments
Table 79. Seagen Next Generation Monoclonal Antibodies Basic Information
Table 80. Seagen Next Generation Monoclonal Antibodies Product Overview
Table 81. Seagen Next Generation Monoclonal Antibodies Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Seagen Business Overview
Table 83. Seagen Recent Developments
Table 84. Astellas Next Generation Monoclonal Antibodies Basic Information
Table 85. Astellas Next Generation Monoclonal Antibodies Product Overview
Table 86. Astellas Next Generation Monoclonal Antibodies Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Astellas Business Overview
Table 88. Astellas Recent Developments
Table 89. Gilead Sciences Next Generation Monoclonal Antibodies Basic Information
Table 90. Gilead Sciences Next Generation Monoclonal Antibodies Product Overview
Table 91. Gilead Sciences Next Generation Monoclonal Antibodies Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Gilead Sciences Business Overview
Table 93. Gilead Sciences Recent Developments
Table 94. GSK Next Generation Monoclonal Antibodies Basic Information
Table 95. GSK Next Generation Monoclonal Antibodies Product Overview
Table 96. GSK Next Generation Monoclonal Antibodies Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. GSK Business Overview
Table 98. GSK Recent Developments
Table 99. Immunocore Next Generation Monoclonal Antibodies Basic Information
Table 100. Immunocore Next Generation Monoclonal Antibodies Product Overview
Table 101. Immunocore Next Generation Monoclonal Antibodies Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Immunocore Business Overview
Table 103. Immunocore Recent Developments
Table 104. ADC Therapeutics Next Generation Monoclonal Antibodies Basic Information
Table 105. ADC Therapeutics Next Generation Monoclonal Antibodies Product Overview
Table 106. ADC Therapeutics Next Generation Monoclonal Antibodies Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. ADC Therapeutics Business Overview
Table 108. ADC Therapeutics Recent Developments
Table 109. Bayer Next Generation Monoclonal Antibodies Basic Information
Table 110. Bayer Next Generation Monoclonal Antibodies Product Overview
Table 111. Bayer Next Generation Monoclonal Antibodies Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Bayer Business Overview
Table 113. Bayer Recent Developments
Table 114. Novartis Next Generation Monoclonal Antibodies Basic Information
Table 115. Novartis Next Generation Monoclonal Antibodies Product Overview
Table 116. Novartis Next Generation Monoclonal Antibodies Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Novartis Business Overview
Table 118. Novartis Recent Developments
Table 119. Lantheus Next Generation Monoclonal Antibodies Basic Information
Table 120. Lantheus Next Generation Monoclonal Antibodies Product Overview
Table 121. Lantheus Next Generation Monoclonal Antibodies Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. Lantheus Business Overview
Table 123. Lantheus Recent Developments
Table 124. Aurobindo Pharma Next Generation Monoclonal Antibodies Basic Information
Table 125. Aurobindo Pharma Next Generation Monoclonal Antibodies Product Overview
Table 126. Aurobindo Pharma Next Generation Monoclonal Antibodies Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. Aurobindo Pharma Business Overview
Table 128. Aurobindo Pharma Recent Developments
Table 129. Mundipharma Next Generation Monoclonal Antibodies Basic Information
Table 130. Mundipharma Next Generation Monoclonal Antibodies Product Overview
Table 131. Mundipharma Next Generation Monoclonal Antibodies Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 132. Mundipharma Business Overview
Table 133. Mundipharma Recent Developments
Table 134. AbbVie Next Generation Monoclonal Antibodies Basic Information
Table 135. AbbVie Next Generation Monoclonal Antibodies Product Overview
Table 136. AbbVie Next Generation Monoclonal Antibodies Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 137. AbbVie Business Overview
Table 138. AbbVie Recent Developments
Table 139. Global Next Generation Monoclonal Antibodies Sales Forecast by Region (2025-2032) & (K MT)
Table 140. Global Next Generation Monoclonal Antibodies Market Size Forecast by Region (2025-2032) & (M USD)
Table 141. North America Next Generation Monoclonal Antibodies Sales Forecast by Country (2025-2032) & (K MT)
Table 142. North America Next Generation Monoclonal Antibodies Market Size Forecast by Country (2025-2032) & (M USD)
Table 143. Europe Next Generation Monoclonal Antibodies Sales Forecast by Country (2025-2032) & (K MT)
Table 144. Europe Next Generation Monoclonal Antibodies Market Size Forecast by Country (2025-2032) & (M USD)
Table 145. Asia Pacific Next Generation Monoclonal Antibodies Sales Forecast by Region (2025-2032) & (K MT)
Table 146. Asia Pacific Next Generation Monoclonal Antibodies Market Size Forecast by Region (2025-2032) & (M USD)
Table 147. South America Next Generation Monoclonal Antibodies Sales Forecast by Country (2025-2032) & (K MT)
Table 148. South America Next Generation Monoclonal Antibodies Market Size Forecast by Country (2025-2032) & (M USD)
Table 149. Middle East and Africa Next Generation Monoclonal Antibodies Consumption Forecast by Country (2025-2032) & (Units)
Table 150. Middle East and Africa Next Generation Monoclonal Antibodies Market Size Forecast by Country (2025-2032) & (M USD)
Table 151. Global Next Generation Monoclonal Antibodies Sales Forecast by Type (2025-2032) & (K MT)
Table 152. Global Next Generation Monoclonal Antibodies Market Size Forecast by Type (2025-2032) & (M USD)
Table 153. Global Next Generation Monoclonal Antibodies Price Forecast by Type (2025-2032) & (USD/MT)
Table 154. Global Next Generation Monoclonal Antibodies Sales (K MT) Forecast by Application (2025-2032)
Table 155. Global Next Generation Monoclonal Antibodies Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Next Generation Monoclonal Antibodies
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Next Generation Monoclonal Antibodies Market Size (M USD), 2019-2032
Figure 5. Global Next Generation Monoclonal Antibodies Market Size (M USD) (2019-2032)
Figure 6. Global Next Generation Monoclonal Antibodies Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Next Generation Monoclonal Antibodies Market Size by Country (M USD)
Figure 11. Next Generation Monoclonal Antibodies Sales Share by Manufacturers in 2023
Figure 12. Global Next Generation Monoclonal Antibodies Revenue Share by Manufacturers in 2023
Figure 13. Next Generation Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Next Generation Monoclonal Antibodies Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Next Generation Monoclonal Antibodies Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Next Generation Monoclonal Antibodies Market Share by Type
Figure 18. Sales Market Share of Next Generation Monoclonal Antibodies by Type (2019-2025)
Figure 19. Sales Market Share of Next Generation Monoclonal Antibodies by Type in 2023
Figure 20. Market Size Share of Next Generation Monoclonal Antibodies by Type (2019-2025)
Figure 21. Market Size Market Share of Next Generation Monoclonal Antibodies by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Next Generation Monoclonal Antibodies Market Share by Application
Figure 24. Global Next Generation Monoclonal Antibodies Sales Market Share by Application (2019-2025)
Figure 25. Global Next Generation Monoclonal Antibodies Sales Market Share by Application in 2023
Figure 26. Global Next Generation Monoclonal Antibodies Market Share by Application (2019-2025)
Figure 27. Global Next Generation Monoclonal Antibodies Market Share by Application in 2023
Figure 28. Global Next Generation Monoclonal Antibodies Sales Growth Rate by Application (2019-2025)
Figure 29. Global Next Generation Monoclonal Antibodies Sales Market Share by Region (2019-2025)
Figure 30. North America Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Next Generation Monoclonal Antibodies Sales Market Share by Country in 2023
Figure 32. U.S. Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Next Generation Monoclonal Antibodies Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Next Generation Monoclonal Antibodies Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Next Generation Monoclonal Antibodies Sales Market Share by Country in 2023
Figure 37. Germany Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Next Generation Monoclonal Antibodies Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Next Generation Monoclonal Antibodies Sales Market Share by Region in 2023
Figure 44. China Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Next Generation Monoclonal Antibodies Sales and Growth Rate (K MT)
Figure 50. South America Next Generation Monoclonal Antibodies Sales Market Share by Country in 2023
Figure 51. Brazil Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Next Generation Monoclonal Antibodies Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Next Generation Monoclonal Antibodies Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Next Generation Monoclonal Antibodies Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Next Generation Monoclonal Antibodies Production Market Share by Region (2019-2025)
Figure 62. North America Next Generation Monoclonal Antibodies Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Next Generation Monoclonal Antibodies Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Next Generation Monoclonal Antibodies Production (K MT) Growth Rate (2019-2025)
Figure 65. China Next Generation Monoclonal Antibodies Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Next Generation Monoclonal Antibodies Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Next Generation Monoclonal Antibodies Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Next Generation Monoclonal Antibodies Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Next Generation Monoclonal Antibodies Market Share Forecast by Type (2025-2032)
Figure 70. Global Next Generation Monoclonal Antibodies Sales Forecast by Application (2025-2032)
Figure 71. Global Next Generation Monoclonal Antibodies Market Share Forecast by Application (2025-2032)
